Immunization at UNGA79
Global health is again on the agenda at the 79th UN General Assembly. Here’s what you need to know.
Collaboration is Key to Combat Measles
With measles spiking in the U.S. and around the world, it’s more important than ever to work together to expand access to lifesaving vaccines.
Vaccines Against Mosquito-Borne Diseases
In honor of World Mosquito Day, we look at the ways in which vaccines have and continue to revolutionize progress against mosquito-borne diseases like dengue and malaria.
On Getting Vaccinated Against HPV
Shot@Life Champion Priyambda Kumra shares her HPV vaccination story, dispels myths about the vaccine, and calls for expanding access.
Public Health at the Paris Olympics
The 2024 Paris Olympics faces an unexpected challenge: a global uptick in vaccine-preventable diseases that impact athletes, organizers, and spectators alike. But preventative measures are underway to safeguard global health.
Youth Voices for Vaccines
In this guest post, Shot@Life College Ambassador Wajiha Mekki looks at the essential role of youth voices in global health advocacy.
Gavi 6.0: Strengthening Global Health Security
In part three of our series on Gavi 6.0, we look at how Gavi’s global immunization work strengthens global health security.
New WHO/UNICEF Data Shows Immunization Rates Stagnating
The latest data on country-level immunization coverage, published by UNICEF and the World Health Organization (WHO), reveals that immunization rates around the world have stagnated on average, though there are also bright spots.
Gavi 6.0: Advancing the UN’s Sustainable Development Goals
In part two of our series on Gavi 6.0, we look at how investing in immunization advances sustainable development.
Gavi 6.0: Diversifying Vaccine Manufacturing
In part one of our series on Gavi 6.0, we look at the move to diversify vaccine manufacturing with the new African Vaccine Manufacturing Accelerator.
Gavi Launches New Strategy for 2026-30
Last week in Paris, Gavi launched the investment case for its new strategic period and announced the African Vaccine Manufacturing Accelerator with national and civil society partners.
Statement on U.S. Five-Year Pledge to Gavi, the Vaccine Alliance
U.S. Administration makes first-ever five-year pledge to support the critical work of Gavi, the Vaccine Alliance.
![The Democratic Republic of the Congo (DRC) just received over 215,000 mpox vaccines from the European Union to curb the spread of the disease.
The mpox outbreaks, a public health emergency of international concern, are centered in the DRC, home to 94% of all reported cases and 99% of related deaths.
According to Dr. Sania Nishtar, CEO of Gavi, “Now that [the vaccines] have arrived, our first priority is to work with our partners to ensure these and other vaccines reach those who need them, as quickly and efficiently as possible.”](https://shotatlife.org/wp-content/plugins/instagram-feed/img/placeholder.png)
Become a Shot@Life Champion
Are you ready to increase your commitment to fight for global vaccine equity? Sign up for an advocacy training and become a Shot@Life Champion!
Join Us